HIGHLIGHTS
- who: Cirrhosis et al. from the Department of Internal Medicine, Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas, Las Nevada, Las Vegas, Las Vegas, USA have published the Article: Review began 05/25/2022 Review ended 05/27/2022 Published 05/31/2022 u00a9 Copyright, in the Journal: (JOURNAL) of May/31,/2022
- what: Through this study, a systematic review was conducted to determine the efficacy and safety of FMT in the treatment of hepatic encephalopathy and rCDI among cirrhotic patients. Was the study question or objective clearly stated?
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.